Navigation Links
Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
Date:12/4/2007

Two International Phase 3 Trials Evaluated Infrequent Dosing of Ustekinumab

in Nearly 2,000 Patients

HORSHAM, Pa. and BEERSE, Belgium, Dec. 4 /PRNewswire/ -- Centocor, Inc. and Janssen-Cilag International NV announced today that regulatory applications have been submitted requesting the approval of ustekinumab (CNTO 1275) in the United States and Europe for the treatment of adult patients with chronic moderate to severe plaque psoriasis. Centocor has submitted a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) and Janssen-Cilag International NV has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA). Ustekinumab is a new, human monoclonal antibody with a novel mechanism of action that targets the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23), naturally occurring proteins that are important in regulating immune responses and that are thought to be associated with some immune-mediated inflammatory disorders, including psoriasis.

It is estimated that 125 million people worldwide have psoriasis, including two percent of both the U.S. and European populations, or some 7.5 million Americans and 10 million Europeans. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe.(1)

The submissions are based on a comprehensive development program including data from two large Phase 3 multicenter, randomized, double-blind, placebo- controlled trials involving nearly 2,000 patients that evaluated the safety and efficacy of ustekinumab in the treatment of moderate to severe plaque-type psoriasis. The primary endpoint of each pivotal study was the proportion of patients who achieved at least a 75 percent reduction in psoriasis as measured by the Psoriasis Area and Severity Index (PASI 75).

"We are very encouraged by the promising results that we have seen through the ustekinumab clinical developmen
'/>"/>

SOURCE Centocor, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CLIA Waiver Submitted for Rapid HIV Test Employs StatSures Barrel Technology
2. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
3. Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer
4. Vanda Pharmaceuticals Submits Iloperidone New Drug Application
5. Peregrine Pharmaceuticals Submits Clinical Protocol for New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
6. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
7. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
8. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
9. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
10. CryoCor Receives FDA Approval for Right Atrial Flutter
11. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015 Research and Markets( ... "Pharmaceutical Packaging Market in North America 2015-2019" report ... in North America to grow ... International regulations regarding safe drug delivery ... in turn fuels adoption of sustainable packaging. Various raw ...
(Date:7/6/2015)... -- E-QURE Corp (OTCQB: EQUR), today announced that Ron ... July 9, 2015. DATE: Thursday, July 9, 2015 ... This will be a live, interactive online event ... in real-time - both in the presentation hall as ... are not able to join the event live on ...
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
Breaking Medicine Technology:North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
... Nov. 2, 2011 LORENZ customers and business partners have ... Article 57(2) of Regulation (EC) 726/2004 and its impact on ... Interest Group for EVMPD – XEVPRM. One of ... registration are the Requirements of Article 57(2) of Regulation (EC) ...
... GenVec, Inc. (Nasdaq: GNVC ) will report financial ... 9, 2011, before the U.S. financial markets open. The announcement ... 10:00 a.m. EST to discuss the company,s third quarter financial ... the live conference call, please dial 877-558-0567 (U.S. or Canada) ...
Cached Medicine Technology:LORENZ' Response to New EU PV Legislation - Regulation No. 1235/2010 and EVMPD 2GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011 2
(Date:7/6/2015)... , ... July 06, 2015 , ... ... from nurses or midwives, yet there is a large gap between the unmet ... research required to improve health outcomes and reduce unnecessary or ineffective treatments or ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... reimbursement for radiology services and ADVOCATE is leading the transition. ADVOCATE, the only ... expertise with their Top 10 Tips for ICD-10. The ten tips are timely ...
(Date:7/6/2015)... ... 06, 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO of ... Seedstock Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be held ... of California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs are ...
(Date:7/6/2015)... ... , ... In a split second, breaking a bone can cause loss of ... fracture through the bone health screenings conducted by American Bone Health trained Peer Educators ... residents need this information to remain independent and strong for many more years,” according ...
(Date:7/6/2015)... ... July 06, 2015 , ... Dr. Lawrence Green is now offering the ... Kybella is a non-surgical method to dissolve fat cells and is the first ... fat deposits under the chin, commonly known as a double chin. Dr. Green participated ...
Breaking Medicine News(10 mins):Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:National Bone Health Screening and Awareness Day 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2
... and education complex in Islamabad to cater to the health ... the twin city of Rawalpindi . ,The complex ... a Health and Education City in the capital, and includes ... dentistry. ,Harvard Medical International (HMI) is a ...
... and a standardized rehabilitation protocol are successful in returning ... today at the 2007 Annual Meeting of the American ... Center. ,Dr. Brunt and colleagues studied the ... to evaluate the experience of athletes undergoing tension-free mesh ...
... of the American Orthopaedic Society for Sports Medicine at ... in the arm bone and soft tissue of the ... help protect them against injury. ,Young baseball ... as they mature, says principal investigator Scott D. Mair, ...
... of sex, a move that is proving highly controversial among ... workers more vulnerable . ,Men who buy sex ... fine or face both, under proposed legislation currently under consultation ... the buying of sex, but not the sale. Procuring, or ...
... what Victoria Beckham is really wishing for, is a baby girl ... that she and hubby David Beckham will try to add to ... hoping theyll be bringing back a bundle of pink from the ... little girl, is because after all those boys in the house, ...
... Institute for Learning and Memory have uncovered a molecular ... traumatic events . ,The work could lead ... adults who suffer each year from persistent, debilitating fears ... Iraq and Afghanistan. ,A study conducted by the ...
Cached Medicine News:Health News:Surgical Repair of Athletic Hernia Speeds Return to Play 2Health News:Surgical Repair of Athletic Hernia Speeds Return to Play 3Health News:Shoulder Protection by Throwing Motion in Baseball Players 2Health News:Prostitutes Fume as Norway Bids to Criminalise Sex Purchases 2Health News:Prostitutes Fume as Norway Bids to Criminalise Sex Purchases 3Health News:First Drug for Post-traumatic Stress Disorder 2
Spectra 2000 Digital Spectrophotometer is designed for quantitative and qualitative analysis in visible range from 320 nm to 1020 nm....
... Spectrophotometer is truly a ... instrumentation. The latest electro-optical ... a radically new design, ... performance unprecedented in a ...
... Quebec Colony Counter allows the user to quickly ... models allows for digital counting or manual counting. ... standard lens increasing magnification to 3.0X. The adjustable ... be raised or lowered. The lens also rotates ...
The Accucount 1000 is designed to automatically count macroscopic objects in a field displaying totals on a highly visible digital readout....
Medicine Products: